0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Articles |

Effect of Apheresis of Low-Density Lipoprotein on Peripheral Vascular Disease in Hypercholesterolemic Patients with Coronary Artery Disease

Abraham A. Kroon, MD; Wim N.J.C. van Asten, PhD; and Anton F.H. Stalenhoef, MD
[+] Article and Author Information

From University Hospital Nijmegen, Nijmegen, the Netherlands. Acknowledgments: The authors thank the nursing staff of the apheresis unit, the staff of the vascular laboratory, and Ms. D. Kampschreur for assistance and Dr. E. de Groot for supervising the analysis of the videotapes at the Laboratory of the Interuniversity Cardiology Institute. Grant Support: By grant 90.065 from the Dutch Heart Foundation and by Merck, Sharp, & Dohme, Haarlem, the Netherlands. Merck, Sharp, & Dohme also provided simvastatin. Separators, adsorption columns, and other disposable materials for the apheresis unit were provided by Kaneka Deutschland, Wiesbaden, Germany. Requests for Reprints: Anton F.H. Stalenhoef, MD, Department of Internal Medicine, 541 AIG, University Hospital Nijmegen, Geert Grooteplein 8, PO Box 9101, 6500 HB Nijmegen, the Netherlands. Current Author Addresses: Dr. Kroon: Department of Internal Medicine, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, the Netherlands.


Copyright ©2004 by the American College of Physicians


Ann Intern Med. 1996;125(12):945-954. doi:10.7326/0003-4819-125-12-199612150-00001
Text Size: A A A

Background: Apheresis of low-density lipoprotein (LDL) is an effective lipid-lowering treatment in hypercholesterolemic patients who have coronary artery disease and are refractory to drugs. More aggressive lipid-lowering therapy may further slow the progression of atherosclerosis.

Objective: To compare the effect of LDL apheresis and simvastatin therapy with the effect of simvastatin therapy alone on the progression of peripheral vascular disease.

Design: Open, randomized, single-center study.

Setting: University hospital.

Patients: 42 men with primary hypercholesterolemia (total cholesterol level > 8.0 mmol/L) and extensive coronary atherosclerosis.

Intervention: Biweekly apheresis of LDL plus simvastatin, 40 mg/d (n = 21), or simvastatin, 40 mg/d (n = 21), for 2 years.

Measurements: Lipid and lipoprotein levels, changes in hemodynamically significant stenoses in the aortotibial tract (measured by ankle:arm systolic blood pressure ratio combined with Doppler spectrum analysis of the femoral artery), and changes in the mean intima-media thickness of three carotid artery segments.

Results: Mean baseline LDL cholesterol levels decreased from 7.8 to 3.0 mmol/L in the apheresis and simvastatin group and from 7.9 to 4.1 mmol/L in the simvastatin-only group; mean lipoprotein(a) levels decreased from 57.0 to 44.5 mg/dL (change, −19%)in the former group and increased from 38.4 to 44.5 mg/dL (change, 15%) in the latter group. In the apheresis group, the number of patients with hemodynamically significant stenoses in the aortotibial tract decreased from 9 to 7; in the simvastatin-only group, the number increased from 6 to 13 (P = 0.002). Mean intima-media thickness decreased by a mean ±SD of 0.05 ± 0.34 mm in the apheresis group and increased by 0.06 ± 0.38 mm in the simvastatin-only group (P < 0.001). According to multiple regression analysis, changes in apolipoprotein B, total cholesterol, and lipoprotein(a) levels accounted for changes in the aortotibial tract (R2 = 0.36); changes in lipoprotein(a) and apolipoprotein A1 levels accounted for changes in the intima-media thickness of the carotid artery (R2 = 0.49).

Conclusions: Aggressive lipid lowering with simvastatin and LDL apheresis decreased the intima-media thickness of the carotid artery and prevented an increase in the number of hemodynamically significant stenoses in the lower limbs. Therapy with simvastatin alone did not prevent progression of carotid or aortotibial vascular disease.

Figures

Grahic Jump Location
Figure 1. The change in trend between both groups is statistically significant ( = 0.002).
The number of patients with hemodynamically significant stenoses in the aortotibial tract at baseline and at 2 years of treatment with low-density lipoprotein (LDL) apheresis plus simvastatin or simvastatin alone.P
Grahic Jump Location
Grahic Jump Location
Figure 2.
Correlation between the change in mean intima-media thickness of the carotid artery and the change in the score of the Doppler spectrum analysis (negative values indicate worsening).
Grahic Jump Location

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Related Point of Care
Topic Collections
PubMed Articles

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)